Research Directory

  1. Interview: 4-Antibody AG - How do you structure a biotech for divestment?

    Friday 27 April 2012

    Interviewee/Contributer: Robert Burns

    Organisation: 4-Antibody AG

    Read more

  2. A Big Pharma deal that shares risk and reward

    Friday 27 April 2012

    Interviewee/Contributer: Bahija Jallal

    Organisation: MedImmune

    Read more

  3. Focus on ophthalmology: new treatment modality

    Friday 27 April 2012

    Interviewee/Contributer: Patrik De Haes

    Organisation: ThromboGenics NV

    Read more

  4. European biotechs rebound sharply

    Friday 27 April 2012

    Interviewee/Contributer: William Ellington

    Organisation: MedNous

    Read more

  5. Due diligence is more than a numbers game

    Friday 27 April 2012

    Interviewee/Contributer: Anthony Sedgwick

    Organisation: Silence Therapeutics Plc

    Read more

  6. Kymab unlocks the power of the mouse

    Saturday 24 March 2012

    Interviewee/Contributer: Andrew Sandham

    Organisation: Kymab Ltd

    Read more

  7. Reforming the EU Clinical Trials Directive

    Saturday 24 March 2012

    Interviewee/Contributer: Kate Law

    Organisation: Cancer Research UK

    Read more

  8. The outlook for new clinical trials legislation in Europe

    Saturday 24 March 2012

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  9. HTA and the road to higher pharma productivity

    Friday 24 February 2012

    Interviewee/Contributer: Johan Strömquist

    Organisation: NDA Group

    Read more

  10. The role of technology providers in biotech

    Friday 24 February 2012

    Interviewee/Contributer: John Burt

    Organisation: PolyTherics Ltd

    Read more